| Host: |
Goat |
| Applications: |
Pep-ELISA/WB |
| Reactivity: |
Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Goat polyclonal antibody anti-Itih4-Mouse (Internal) is suitable for use in ELISA and Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
| Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Concentration: |
0.5 mg/mL |
| Dilution Range: |
Peptide ELISA: antibody detection limit dilution 1:32000.WB: Approx 100kDa band observed in Rat Liver lysates (calculated MW of 104kDa according to Rat NP_062242.2). Recommended concentration: 0.03-0.1µg/ml. |
| Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
| Immunogen Region: |
Internal |
| Accession Number: |
NP_061216.2; NP_001152771.1 |
| Specificity: |
This antibody is expected to recognize both reported isoforms (NP_002209.2; NP_001159921.1). |
| Immunogen Sequence: |
KPEGQEQFQVAEKP |
| Post Translational Modifications | May be O-glycosylated. N-glycosylated. |
| Function | Type II acute-phase protein (APP) involved in inflammatory responses to trauma. May also play a role in liver development or regeneration. |
| Protein Name | Inter Alpha-Trypsin Inhibitor - Heavy Chain 4Iti Heavy Chain H4Iti-Hc4Inter-Alpha-Inhibitor Heavy Chain 4 |
| Database Links | Reactome: R-MMU-114608 |
| Cellular Localisation | Secreted |
| Alternative Antibody Names | Anti-Inter Alpha-Trypsin Inhibitor - Heavy Chain 4 antibodyAnti-Iti Heavy Chain H4 antibodyAnti-Iti-Hc4 antibodyAnti-Inter-Alpha-Inhibitor Heavy Chain 4 antibodyAnti-Itih4 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
